China Pharma (CPHI) Competitors $0.20 +0.01 (+3.86%) (As of 02:00 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends CPHI vs. KZIA, NRXP, PMCB, AIM, SLGL, NLSP, WENA, SNSE, NKGN, and AWHShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include Kazia Therapeutics (KZIA), NRx Pharmaceuticals (NRXP), PharmaCyte Biotech (PMCB), AIM ImmunoTech (AIM), Sol-Gel Technologies (SLGL), NLS Pharmaceutics (NLSP), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), NKGen Biotech (NKGN), and Aspira Women's Health (AWH). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Kazia Therapeutics NRx Pharmaceuticals PharmaCyte Biotech AIM ImmunoTech Sol-Gel Technologies NLS Pharmaceutics ANEW Medical Sensei Biotherapeutics NKGen Biotech Aspira Women's Health Kazia Therapeutics (NASDAQ:KZIA) and China Pharma (NYSE:CPHI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership, profitability and earnings. Does the media refer more to KZIA or CPHI? In the previous week, China Pharma had 1 more articles in the media than Kazia Therapeutics. MarketBeat recorded 1 mentions for China Pharma and 0 mentions for Kazia Therapeutics. China Pharma's average media sentiment score of 0.38 beat Kazia Therapeutics' score of 0.00 indicating that China Pharma is being referred to more favorably in the news media. Company Overall Sentiment Kazia Therapeutics Neutral China Pharma Neutral Do insiders & institutionals believe in KZIA or CPHI? 30.9% of Kazia Therapeutics shares are held by institutional investors. 1.0% of Kazia Therapeutics shares are held by insiders. Comparatively, 17.3% of China Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger earnings & valuation, KZIA or CPHI? China Pharma has higher revenue and earnings than Kazia Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKazia Therapeutics$1.51M9.81-$13.78MN/AN/AChina Pharma$7.01M0.55-$3.08MN/AN/A Which has more risk and volatility, KZIA or CPHI? Kazia Therapeutics has a beta of 2.08, indicating that its stock price is 108% more volatile than the S&P 500. Comparatively, China Pharma has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Does the MarketBeat Community believe in KZIA or CPHI? Kazia Therapeutics received 79 more outperform votes than China Pharma when rated by MarketBeat users. Likewise, 52.67% of users gave Kazia Therapeutics an outperform vote while only 0.00% of users gave China Pharma an outperform vote. CompanyUnderperformOutperformKazia TherapeuticsOutperform Votes7952.67% Underperform Votes7147.33% China PharmaOutperform VotesNo VotesUnderperform Votes72100.00% Do analysts recommend KZIA or CPHI? Kazia Therapeutics currently has a consensus target price of $20.00, suggesting a potential upside of 256.51%. Given Kazia Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Kazia Therapeutics is more favorable than China Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kazia Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00China Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is KZIA or CPHI more profitable? Kazia Therapeutics has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. Kazia Therapeutics' return on equity of 0.00% beat China Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Kazia TherapeuticsN/A N/A N/A China Pharma -85.56%-63.93%-31.42% SummaryKazia Therapeutics beats China Pharma on 11 of the 16 factors compared between the two stocks. Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$3.84M$6.53B$5.10B$20.16BDividend YieldN/A8.11%5.04%3.49%P/E RatioN/A5.5095.1237.74Price / Sales0.55375.021,217.3018.58Price / CashN/A52.5939.4921.28Price / Book0.5910.276.974.65Net Income-$3.08M$153.22M$118.73M$985.06M7 Day Performance-0.30%-1.19%-1.22%1.65%1 Month Performance-16.61%-6.71%-3.07%2.32%1 Year Performance-56.67%32.39%32.52%26.39% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina PharmaN/A$0.20+3.9%N/A-59.6%$3.84M$7.01M0.00231KZIAKazia Therapeutics1.8779 of 5 stars$5.61flat$20.00+256.5%-26.9%$14.81M$1.51M0.0012NRXPNRx Pharmaceuticals1.9932 of 5 stars$1.21flat$31.50+2,503.3%-96.1%$14.63MN/A0.002PMCBPharmaCyte Biotech0.6454 of 5 stars$1.79+4.1%N/A-21.1%$13.75MN/A2.612AIMAIM ImmunoTech1.7374 of 5 stars$0.21+5.4%$3.00+1,323.8%-52.0%$13.42M$200,000.00-0.4520News CoverageSLGLSol-Gel Technologies3.6128 of 5 stars$0.48+8.6%$5.00+943.8%-68.5%$13.35M$1.55M-1.3050News CoverageGap DownNLSPNLS Pharmaceutics1.2189 of 5 stars$3.34+1.5%N/A+623.1%$12.76MN/A0.006WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8056 of 5 stars$0.48-2.8%$4.33+795.3%-20.0%$12.17MN/A0.0040News CoverageNKGNNKGen BiotechN/A$0.34+7.9%N/A-89.1%$11.94M$80,000.00-0.06N/AGap UpHigh Trading VolumeAWHAspira Women's Health1.533 of 5 stars$0.74+1.4%$4.40+494.6%-78.5%$11.88M$9.15M-0.64110Analyst Forecast Related Companies and Tools Related Companies Kazia Therapeutics Competitors NRx Pharmaceuticals Competitors PharmaCyte Biotech Competitors AIM ImmunoTech Competitors Sol-Gel Technologies Competitors NLS Pharmaceutics Competitors ANEW Medical Competitors Sensei Biotherapeutics Competitors NKGen Biotech Competitors Aspira Women's Health Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CPHI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
